Annexon, Inc. Balance Sheet
ANNX / Health Care|6 years of annual SEC 10-K data (FY2019-FY2024)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 6 fiscal years. All figures from audited SEC 10-K filings.
Annexon, Inc. had $350M in total assets and $293M in shareholders' equity as of FY2024.
Based on SEC 10-K filings.
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $49.5M | $225.1M | $140.0M | $74.8M | $268.6M | $43.9M |
| Current Assets | $316.5M | $263.9M | $248.1M | $247.7M | $354.0M | $45.4M |
| PP&E (Net) | $12.6M | $14.8M | $16.8M | $17.8M | $1.9M | $2.1M |
| Total Assets | $350.1M | $297.7M | $285.1M | $287.0M | $355.9M | $49.9M |
| Current Liabilities | $30.5M | $17.9M | $22.4M | $21.7M | $10.6M | $4.9M |
| Shareholders' Equity | $293.1M | $250.6M | $231.2M | $231.9M | $344.3M | -$100.5M |